MMP13 and breast carcinoma: Another study highlights the role of TLR9 in highly invasive MDA-MB-231 breast cancer cell line which when activated promotes MDA-MB-231 cell invasion by increasing the activity of matrix metalloproteinase 13 (MMP13), but not MMP8 [42].